Kestra Medical Technologies, Inc. (KMTS): Market Cap to Revenue

Symbol and logo of brand Kestra Medical Technologies, Inc. (KMTS)

The current price-to-sales ratio demonstrates market expectations, where the 15.90 level reflects the current magnitude. This trend is driven by device marketing costs and slow recognition by insurers. Kestra Medical Technologies (KMTS) focuses on creating compact defibrillators for 24/7 patient monitoring. Meanwhile, strict FDA oversight and patent protection create significant barriers to entry for new players in the cardiology sector.

KMTS Kestra Medical Technologies, Inc. P/S Multiple (03/07/2025 - 11/13/2026)

Analytical breakdowns for Kestra (KMTS)

- share price and consensus valuation forecast:
Price Performance Chart kestramedical.com|KMTS - Price Target Chart
- stock exchange capitalization data:
Market Valuation Kestra|KMTS - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Kestra Medical Technologies|KMTS - Book Capitalization|Capitalization to Book Value Ratio kestramedical.com|KMTS - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Kestra Medical Technologies|KMTS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Kestra Medical Corp|KMTS - Company Aggregate Debts|Debts to Book Capitalization Kestra|KMTS - Company Long-Term Debt|Company Short-Term Debt Kestra Medical Technologies|Intermediate Coverage Ratio kestramedical.com
- earnings and multiples data:
KMTS - Net Income|Future Net Profit Kestra Medical Technologies|KMTS - P/E Multiple|Projected Price to Earnings Ratio Kestra Medical Technologies, Inc.|KMTS - PEG Multiple|Enterprise Value to EBITDA Ratio Kestra|KMTS - Operating profit EBITDA|Earnings per share for the trailing year Kestra Medical Technologies|KMTS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months kestramedical.com|KMTS - Earnings per share growth in current year|Expected net earnings per share growth next year Kestra Medical Technologies
- issuer revenue and sales details:
KMTS - Company Revenue|Company Projected Revenue kestramedical.com|KMTS - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Kestra
General company analysis:KMTS kestramedical.com
Core merchandise of Kestra Medical Technologies

Kestra Medical Technologies is developing an ecosystem of wearable defibrillators with guaranteed customer retention driven by strict FDA oversight. The price-to-sales ratio measures the market value of every dollar of revenue; therefore, any fluctuation in P/S reflects investor reaction to strategic news, where extremes signal either a critical overvaluation or a potential undervaluation of the business.

Competitors of Kestra Medical Technologies

REGN (regeneron.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio iRhythm IRTC|LNTH - Market Cap to Revenue|Mineralys Therapeutics Inc - P/S Multiple|Price to Sales Heartflow Inc|ESPR: P/S Multiple|Market Cap to Revenue Ratio AMRN|AVR (Anteris) - P/S Multiple|Tenaya Therapeutics Inc (TNYA) - Price-to-Revenue Coefficient|P/S Multiple CVRX|Market Cap to Revenue Milestone Pharmaceuticals Inc MIST|P/S Multiple CRDL (Cardiol Therapeutics Inc.)|P/S Multiple heartbeam.com BEAT|TENX - Price-to-Revenue Ratio|ADGM: Price-to-Revenue Ratio|BCDA (BioCardia, Inc) - Market Cap to Revenue|Catheter Precision Corporation - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue ABIO|ACST (Acasti) - Market Cap to Sales Volume|P/S Multiple AVTE|VERV - Price to Sales|P/S Multiple WINT (Windtree Therapeutics, Inc.)